中新网北京11月20日电 (欧阳开宇 曾利明)中国已有近千家医疗机构采用微创手术治疗癌症，每年开展手术26000台以上，治疗技术和肿瘤治愈率已达到国际先进水平。这是中国肿瘤微创治疗产业技术创新联盟理事长郑加生教授今天发布的信息。

Beijing Beijing November 20 report (OuYangKaiYu CengLiMing)China had nearly thousand medical organizations to adopt minimally invasive surgical treatment of cancer,To carry out surgery each year more than 26000 sets,Treatment technology and tumor cure rate has reached the international advanced level.This is China's tumor minimally invasive treatment industrial technology innovation alliance ZhengJiaSheng professor of information released today.

　　他在此间闭幕的“2012中国微创介入医学学术大会”透露，目前中国每年约新增癌症患者230万例，仅肝癌和肺癌每年新发病人就有90万。由于癌症早期诊断率低，60%以上的患者确诊时已属于中晚期，能进行传统根治性手术切除的不足20%，大多数患者失去了无瘤生存的可能。

He is in here the closing"2012 China minimally invasive intervention medical academic conference"revealed,China's new cancer cases every year about 2.3 million cases,Only liver cancer and lung cancer each year 900000 new cases are.Because cancer early diagnosis rate is low,More than 60% of the patients diagnosed, has belongs to mid and late stage,Can carry on the traditional radical surgery of less than 20%,Most patients without tumor survival may lose.

　　采用由磁共振、彩色超声、手术导航系统等形成的微创手术治疗肿瘤，具有定位精确、创伤小、并发症少、适应范围广，对患者机体打击轻微，可最大限度保护人体器官功能等优势。临床统计显示，60%以上的中晚期患者可以通过微创手术得到肿瘤根治性治疗的机会。

Used by the magnetic resonance/Color ultrasonic/Surgical navigation system and formation of minimally invasive surgical treatment of tumor,Has the positioning precision/Trauma small/Fewer complications/Adapt to a wide range,For patients with mild body blow,Can maximum limit to protect human organ function etc advantages.Clinical statistics show that,More than 60% of the patients with middle-late by minimally invasive surgery for tumors radical treatment opportunity.

　　郑教授提供的资料显示：北京佑安医院肿瘤微创介入中心采用射频消融、微波消融技术对不能接受传统手术治疗的中晚期肝癌患者，实现了中晚期肿瘤患者无瘤生存的可能。目前治疗中晚期肝癌患者487例，消融最大肿瘤直径12厘米，患者1年生存率为97.7%，3年生存率达到71%。采用动脉化疗栓塞结合射频或微波消融的方法，近3年共治疗这类患者133例，1年生存率为87%，3年生存率达到41.4%，这项技术达到国际领先水平。

Professor zheng provided information display:Beijing youan hospital cancer center, minimally invasive intervention using radio frequency ablation/Microwave ablation technique to can't accept the traditional surgical treatment of patients with hepatocellular carcinoma (HCC) middle-late,Realize the disease-free survival in middle-late cancer patients may.Current treatments of mid and late stage liver cancer patients in 487 cases,Ablation maximum tumor diameter 12 cm,Patients 1-year survival was 97.7%,3 year survival rate reached 71%.The tace combined with rf or microwave ablation method,Nearly three years a total of 133 cases of treatment of these patients,1 year survival rate was 87%,3 year survival rate reached 41.4%,The technology has reached the international advanced level.

　　北京宣武医院对75岁以上高龄、有合并症、心肺功能较差、不能耐受开胸手术和放化疗的非小细胞肺癌患者，进行了微创射频消融手术治疗的探索。采用结合分子靶向药物联合治疗400多例非小细胞肺癌患者，手术消融最大肿瘤为13厘米，有效地提高了患者的生存率，接受射频消融治疗的前100例患者2年生存率达到了57.7%。

Beijing xuanwu hospital for more than 75 years old/Have complicated/Cardiopulmonary function is poor/Can't tolerate open chest surgery and chemotherapy of non-small cell lung cancer,The radio frequency ablation minimally invasive surgical treatment of exploration.The combined with molecular targeted drug combination therapy of more than 400 patients in non-small cell lung cancer,Surgical ablation maximum tumor for 13 cm,Effectively improve the patient's survival,Accept radiofrequency ablation therapy in 100 patients before 2 years of survival rate reached 57.7%.

　　解放军307医院开展的超声消融治疗胰腺癌研究，使168位中晚期胰腺癌患者一年生存率达到50%以上，三年生存率达到15%以上，有效地延长了患者生存期。

The people's liberation army 307 hospital of ultrasound ablation treatment of pancreatic cancer research,Make 168 patients with pancreatic cancer middle-late a year survival rate above 50%,Three years of survival rate above 15%,Effectively prolong the survival period.

　　郑教授称，为进一步推广普及肿瘤微创治疗技术，今年4月国家科技部批准中国肿瘤微创治疗产业技术创新联盟为国家试点联盟。目前，全国已有1600多名从事肿瘤消融治疗的医师接受了各类专业技术培训。联盟建议有条件的医院设立具有CT、磁共振、超声、数字减影设备与微创介入技术相结合的手术室，建立微创介入病房，进一步提高微创手术的安全性和有效性。联盟将建立10家微创治疗肿瘤中心、100家微创治疗肿瘤示范医院，积极推广各种先进的微创治疗肿瘤技术，使更多的肿瘤患者得到有效的治疗。”

Professor zheng said,In order to further expand the tumor minimally invasive treatment technology,In April this year approved by the state ministry of science and technology of China tumor minimally invasive treatment industrial technology innovation coalition for national pilot alliance.At present,The national more than 1600 engaged in tumor ablation treatment of physicians have received various kinds of professional and technical training.Alliance suggest conditional hospital set up with CT/Magnetic resonance/ultrasonic/Digital subtraction angiography (dsa) equipment and minimally invasive interventional techniques in combination of the operating room,Establish minimally invasive intervention ward,To further improve the safety and efficacy of minimally invasive surgery.Alliance will build 10 minimally invasive treatment of cancer center/100 minimally invasive treatment tumor demonstration hospital,Actively promote various kinds of advanced minimally invasive treatment tumor technology,Make more cancer patients get effective treatment."

　　据知，中国肿瘤微创治疗技术创新战略联盟已出版发行消融治疗肝肿瘤专著、肿瘤射频消融治疗操作规范及多种微创消融手术影像资料。联盟理事单位目前已取得了两项“十二五”国家重大科技支撑项目、一项重大传染病专项课题。

It is considered that,China tumor minimally invasive treatment technology innovation strategy alliance has published ablation treatment of liver tumor monographs/Tumor rf ablation treatment operation specifications and a variety of minimally invasive ablation surgical image data.Union director unit has made two"1025"Major national science and technology support project/A major infectious disease special subject.

　　来自全国28个省、自治区、直辖市的500多名专家及代表对特殊部位肝癌的消融治疗、肺肿瘤消融、骨肿瘤消融、超声聚焦、粒子植入肿瘤近距离放疗及腔镜技术等开展了技术交流和手术演示。(完)

From the country 28 provinces/Autonomous region/Municipalities directly under the central government on behalf of more than 500 experts and the special site liver cancer ablation therapy/Lung tumor ablation/Bone tumor ablation/Ultrasonic focusing/Implanted tumor brachytherapy and cavity mirror technology to carry out the technical exchanges and surgical demo.(finish)